The Preclinical CRO Focused on Infectious Disease
We leverage a validated portfolio of preclinical assays and in vivo disease models backed by internationally recognized expertise in immunology and infectious diseases to support preclinical-stage drug discovery and development.
Infectious Disease Models
Infectious diseases remain a leading cause of morbidity and mortality worldwide. In vivo mouse models facilitate evaluation of the effectiveness of vaccines and/or therapeutic regimens as well as their potential to alter immune cell responses to infection.
Diagnostic Assays
TICRO boasts qualified, highly trained personnel combined with access to state-of-the-art facilities, including Immunohistochemistry, Flow Cytometry, Microscopy and Imaging and Molecular Biology Core Facilities, to meticulously conduct experiments and assays according to study specifications.
Injections & Surgery
Our in vivo models facilitate the study of the pathogenesis and complications of infectious disease, and permit preclinical evaluations of treatment protocols as a precursor to clinical studies.